Home »
Clinical research is one of the principle foundations of our practice.
We believe that advances in understanding the nature of neuromuscular diseases and exploring new ways to diagnose and treat them is key to the care of our patients. Our team of research coordinators, research managers, infusion therapists and pharmacy liaisons routinely communicate and collaborate with top researchers worldwide to find answers to our patients’ concerns.
We have a long history of originating therapeutic drug trials referred to as Phase 1 studies and frequently partner with foundations such as ALS Association and The Muscular Dystrophy Association as well as with pharmaceutical companies during larger, later phase drug trials.
Our current trials are listed below
Enrolling Studies as of 07/01/2024
| Study Name | Coordinator | Contact | Disease | Study Description |
|---|---|---|---|---|
|
Repository for Genetic & Biomarker |
Shannon Stevens, BSN, BS, CNRN, RN |
(332) 334-6637 |
ALS |
This study shares blood specimens with co-investigators for discovery of the basis of disease and new genetic variants. |
|
Shannon Stevens, BSN, BS, CNRN, RN |
(332) 334-6637 |
ALS |
This is a multicenter, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early-stage ALS (within 2 years of ALS symptoms onset). The study comprises a core double-blind (DB) 40-week treatment period followed by an open label extension (OLE). |